ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Decision analysis"

  • Abstract Number: 1619 • ACR Convergence 2020

    Immunoglobulin G Subclass Ordering Patterns for IgG4-Related Disease at an Academic Medical Center

    Lena Eder1 and David Leverenz2, 1Duke University Hospital, Chapel Hill, NC, 2Duke University, DURHAM, NC

    Background/Purpose: We have noticed an increasing number of serum IgG4 levels ordered over the last several years at our institution. This study was performed to…
  • Abstract Number: 1699 • ACR Convergence 2020

    Training Residents to ‘Choose Wisely’ When Testing for Antinuclear Antibodies

    Iman Qaiser1, Tracy Koehler1 and Richard Martin2, 1Mercy Health Saint Mary's, Grand Rapids, MI, 2Michigan State University College of Human Medicine, Grand Rapids, MI

    Background/Purpose: In many hospitals residents are the first providers to evaluate new patients. Consequently, residents often initiate the work-up of newly admitted patients. Multiple studies…
  • Abstract Number: 1707 • ACR Convergence 2020

    Development and Delivery of Continuing Education Interventions Promoting Shared Decision Making in Rheumatoid Arthritis

    Richard Martin1, Marianna Shershneva2 and Lily Zurkovsky3, 1Michigan State University College of Human Medicine, Grand Rapids, MI, 2Senior Administrative Program Specialist, Office of Continuing Professional Development University of Wisconsin School of Medicine and Public Health, Madison, WI, 3Forefront Collaborative, Carmel, IN

    Background/Purpose: A core CMS policy goal is to improve patient experience by encouraging patient-centered care and shared decision making (SDM).  However, SDM techniques are underutilized…
  • Abstract Number: 1723 • ACR Convergence 2020

    RA Flare Prediction via Machine Learning and Algorithm Based on SSDM Big Data

    Yan Zhao1, Rong Mu2, Xiaomei Li3, Hongsheng Sun4, Cundong Mi5, Guosheng Wang3, Shengqian Xu6, Minghua Xu7, Haiying Chen8, Qingchun Huang9, Ling Lei10, HaiLi Shen11, Hui Xiao12, Yuhua Jia13, Bing Wu13, Xin Chen12, Shengsong Jia12 and Fei Xiao13, 1Peking Union Medical College hospital, Beijing, Beijing, China (People's Republic), 2People's Hospital, Beijing University Medical School, Beijing, Beijing, China (People's Republic), 3the First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, China (People's Republic), 4Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China (People's Republic), 5The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China (People's Republic), 6the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China (People's Republic), 7Affiliated Hospital of Hebei University, Baoding, Hebei, China (People's Republic), 8The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (People's Republic), 9Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China (People's Republic), 10The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China (People's Republic), 11Second Hospital of Lanzhou University, Lanzhou, Gansu, China (People's Republic), 12Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 13Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China (People's Republic)

    Background/Purpose: Flare, relapse from status of treat-to-target (T2T, DAS28< =3.2), is hard predicted. We try to make it predictable by applying machine learning to a…
  • Abstract Number: 1774 • ACR Convergence 2020

    Making Decisions About Medication Use, Pregnancy, and Having Children Among Women with Rheumatoid Arthritis: A Constructivist Grounded Theory Study

    Nevena Rebic1, Ria Garg2, Sarah Munro2, Glen Hazlewood3, Neda Amiri2, Nick Bansback2, Stephanie Ensworth2, Corisande Baldwin4, Laurie Proulx5 and Mary De Vera1, 1Arthritis Research Canada, University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3University of Calgary, Calgary, AB, Canada, 4University of British Columbia, Calgary, AB, Canada, 5Canadian Arthritis Patient Alliance, Ottawa, Canada

    Background/Purpose: Despite guidelines for managing rheumatoid arthritis (RA) in pregnancy, high rates of discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) considered safe for women with RA…
  • Abstract Number: 0244 • ACR Convergence 2020

    What Are the Early versus Late Predictors for Systemic Lupus Erythematosus (SLE) Diagnosis?

    Yiting Wang1, Kirsten Lum2, Karen Costenbader3, Grace Wang4, Jennifer Lofland5, Dominik Naessens6, Yihan Zhao7, Kourtney Davis8 and Chetan Karyekar9, 1Janssen Research & Development, LLC, Newark, DE, 2Janssen Pharm Technology - Data Sciences and Data Management, Horsham, PA, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Janssen Pharmaceuticals, Horsham, 5Janssen Global Market Access, horsham, PA, 6Jassen Global Market Access, Beerse, Belgium, 7Janssen Pharm Technology - Data Sciences and Data Management, Horsham, 8Janssen R&D, LLC, Titusville, NJ, 9Janssen Global Services, LLC, Horsham, PA

    Background/Purpose: SLE is clinically heterogenous and its diagnosis is often difficult or delayed. The length of time from symptom onset or from when patients seek…
  • Abstract Number: 0535 • ACR Convergence 2020

    Provider Opinion and Support for Shared Decision-making in Gout Treatment: A Quality Improvement National Survey of Veterans Affairs Rheumatologists

    Jasvinder Singh1, John Richards2, Elizabeth Chang3, Toupin-April, Karine Toupin-April4 and Jennifer Barton5, 1University of Alabama at Birmingham, Birmingham, AL, 2Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 3Phoenix VA Medical Center, Phoenix, AZ, Phoenix, AZ, 4VA Portland Oregon, Portland, OR, 5Oregon University, Portland, OR

    Background/Purpose: To assess rheumatologists’ views and practices related to shared decision making (SDM) in gout treatment.Methods: We performed a cross-sectional electronic survey of rheumatologists at…
  • Abstract Number: 0750 • ACR Convergence 2020

    Nuclei Detection in Rheumatoid Arthritis Synovial Tissue Using Artificial Intelligence

    Steven Guan1, David Slater1, James Thompson1, Edward DiCarlo2, Diyu Pearce-Fisher2, Susan Goodman3, Bella Mehta4 and Dana Orange5, 1MITRE, McLean, VA, 2Hospital for Special Surgery, New York, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 5Rockefeller University, New York

    Background/Purpose: Hematoxylin and eosin (H&E) stained rheumatoid arthritis synovium are routinely used to assess inflammation [1]. In this work, we propose an automated approach using…
  • Abstract Number: 1595 • ACR Convergence 2020

    Using Rheumatoid Arthritis Communication Tool Developed by the RISE Learning Collaborative to Promote Shared Decision-Making

    Joad Eseddi1, Puneet Bajaj2, Gabriela Schmajuk3, Jinoos Yazdany4 and Salahuddin Kazi5, 1UT Southwestern Medical Center, Dallas, TX, 2UT Southwestern, Dallas, TX, 3University of California, San Francisco, Atherton, CA, 4University of California, San Francisco, San Francisco, CA, 5Veterans Affairs North Texas Healthcare System / UT Southwestern Medical Center, Dallas, TX

    Background/Purpose: Patient care is moving from physician directed treatment to a co-design framework that focuses on creating a partnership between patients and physicians. This new…
  • Abstract Number: 1597 • ACR Convergence 2020

    Use of a Clinical Dashboard Improves the Documentation of Disease Severity Scores and May Facilitate the Implementation of Treat to Target Therapy

    Taylor Nelson1, Gary Kunkel2 and Grant Cannon2, 1University of Utah, Salt Lake City, 2Salt Lake City VA Medical Center and University of Utah, Salt Lake City

    Background/Purpose: Rheumatoid Arthritis (RA) management guidelines recommend the collection of Disease Activity Measures (DAMs) to direct therapy as a component of a “treat-to-target” (T2T) strategy. …
  • Abstract Number: 036 • 2020 Pediatric Rheumatology Symposium

    Medication Related Decision-Making in Parents of Children with Juvenile Idiopathic Arthritis

    Alexandra Munroe1, Adam Huber 2, Bianca Lang 3, Suzanne Ramsey 4 and Elizabeth Stringer 4, 1Dalhousie University, Halifax, Nova Scotia, Canada, 2IWK Health Centre & Dalhousie University, Halifax, Nova Scotia, Canada, 3Dalhousie University - Halifax, Halifax, Canada, 4IWK Health Centre, Halifax, Canada

    Background/Purpose: Outcomes for juvenile idiopathic arthritis (JIA) have improved with use of disease-modifying anti-rheumatic drugs (DMARDs) and biologics. Despite this, the decision by a parent…
  • Abstract Number: 1355 • 2019 ACR/ARP Annual Meeting

    A Comparison of Clinical Improvement Following a Major Therapeutic Change Utilizing Updated Treatment Thresholds Defined by Three Different Disease Activity Measures

    Grant Cannon1, Wei Chen 1, JIncheng Shen 2, Neil Accortt 3, David Collier 4 and Brian Sauer 1, 1Salt Lake City VA Medical Center and Univeristy of Utah, Salt Lake City, UT, 2Univeristy of Utah, Salt Lake City, UT, 3Amgen, Thousand Oaks, CA, 4Amgen Inc., Thousand Oaks, CA

    Background/Purpose: Despite ACR recommendations to initiate a major therapeutic change (MTC) in rheumatoid arthritis (RA) patients with moderate/severe disease activity, our recent work has shown…
  • Abstract Number: 411 • 2017 ACR/ARHP Annual Meeting

    Factors That Drive Treatment Recommendation during Rheumatoid Arthritis Patient´s Follow-up, Differ According to Physician Experience

    César Sifuentes-Cantú1, Irazu Contreras-Yañez2, Lina Saldarriaga Rivera3, Ana Cecilia Lozada4, Marwin Gutierrez5 and Virginia Pascual-Ramos1, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 3Instituto Nacional de Rehabilitación, Mexico, Mexico, 4Division of musculoskeletal and rheumatic diseases, Instituto Nacional de Rehabilitación, Mexico City, Mexico, 5Rheumatology, Instituto Nacional de Rehabilitación, Mexico City, Mexico

    Background/Purpose: The management plan for rheumatoid arthritis (RA) might be a relatively simple task if only disease activity is considered but might become more complex…
  • Abstract Number: 1045 • 2017 ACR/ARHP Annual Meeting

    The Potential Value of a Shared Decision-Making Intervention for Choices Regarding Triple Therapy in Rheumatoid Arthritis

    Nick Bansback1, Tima Mohammadi2, Aslam Anis3, James R. O'Dell4 and Glen Hazlewood5, 1School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, 2Centre for Health Evaluation and Outcome Sciences, Vancouver, BC, Canada, 3University of British Columbia, School of Population and Public Health, Vancouver, BC, Canada, 4Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 5Division of Rheumatology, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Previous studies have shown that using Triple Therapy (a combination of 3 generic drugs) prior to a biologic, is the most cost-effective strategy for…
  • Abstract Number: 1052 • 2017 ACR/ARHP Annual Meeting

    Systematic Review of Modelling Approaches and Quality for the Cost Effectiveness of sequential Targeted Therapy in Patients with Rheumatoid Arthritis That Show an Inadequate Response to at Least One Tumor Necrosis Factor Alpha Inhibitor

    Aliza Matusevich1, Maria Suarez-Almazor1, Scott B. Cantor2 and Maria A. Lopez-Olivo1, 1Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, 2Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX

    Background/Purpose: Results from cost-effectiveness analysis (CEAs) comparing treatment options for patients with rheumatoid arthritis (RA) who have an inadequate response to an initial tumor necrosis…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.